EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Age-related cerebral amyloid angiopathy accumulation in the APPSw mouse model is associated with perivascular inflammation and brain-wide vascular and inflammatory gene and protein changes

Katelynn E Krick, Erica M Weekman, Sherika N Johnson, Tiffany L Sudduth, Colin B Rogers, Emma J Nicolayson, Maureen T Kleinhenz, Donna M Wilcock

Neurobiology of Disease · 2025

DOI: 10.1016/j.nbd.2025.107013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurobiology of Disease, 2025. Verfasst von Katelynn E Krick und 7 weiteren Autor:innen. Beteiligte Einrichtung: Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Sanders-Brown Center on Aging, University…. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Brain, Alzheimer Disease, Aging. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral amyloid angiopathy (CAA) is an extremely common pathology of Alzheimer's disease (AD) included under vascular contributions to cognitive impairment and dementia (VCID). CAA has been reported in 78-98 % of AD cases and has clinical significance when considering side effects that arise when using amyloid targeting immunotherapies. Despite its prevalence, studies addressing CAA mechanisms have been scarce and there are clear gaps in our understanding of how CAA progresses. This study uses Tg2576 mice, who develop CAA over time, to establish a time course of CAA progression at 8-, 14-, and 20-months of age. We identify changes in transcriptomic signatures of glial cells using NanoString nCounter and targeted protein changes using NanoString Digital Spatial Profiling. Meso Scale Discovery and immunohistochemistry are used to establish disease progression. In this study, we saw many changes primarily associated with inflammatory response, with some changes being transient (Tnf, Lsr; VEGF) and others remaining chronically altered (Osmr, Ccl3; CTSD). Overarchingly, many of these changes relate to the perpetuation of inflammation or recruiting additional immune support, which we see across our timepoints. Further, we identified differences in abundance of proteins (CD45, GFAP, CD31) based on presence of CAA positive vessels within a brain region. We also identified sex-specific differences in CAA burden, as well as how glial reactivity and vessel density change during disease progression. This data represents a comprehensive analysis of CAA progression and differential responses to parenchymal and vascular amyloid that could inform future basic and clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral Amyloid AngiopathyBrainAlzheimer DiseaseAgingInflammationGlymphatic SystemAnimalsMiceMice, TransgenicMaleFemaleDisease Models, AnimalAmyloid beta-Protein PrecursorDisease Progression

Stichwörter der Autor:innen

Alzheimer's disease (AD)Cerebral amyloid angiopathy (CAA)CerebrovasculatureVascular contributions to cognitive impairment and dementia (VCID)

Substanzen

Amyloid beta-Protein Precursor

Autor:innen und Institutionen

  • Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA.
  • Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA. Electronic address: eweekman@i…
  • Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA.
  • Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA. Electronic address: dwilcock@i…

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Krick, K. E., Weekman, E. M., Johnson, S. N., Sudduth, T. L., Rogers, C. B., Nicolayson, E. J., Kleinhenz, M. T., & Wilcock, D. M. (2025). Age-related cerebral amyloid angiopathy accumulation in the APPSw mouse model is associated with perivascular inflammation and brain-wide vascular and inflammatory gene and protein changes. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2025.107013

Vancouver

Krick KE, Weekman EM, Johnson SN, Sudduth TL, Rogers CB, Nicolayson EJ, et al. Age-related cerebral amyloid angiopathy accumulation in the APPSw mouse model is associated with perivascular inflammation and brain-wide vascular and inflammatory gene and protein changes. Neurobiology of Disease. 2025. doi:10.1016/j.nbd.2025.107013

BibTeX
@article{Krick2025,
  author = {Krick, Katelynn E and Weekman, Erica M and Johnson, Sherika N and Sudduth, Tiffany L and Rogers, Colin B and Nicolayson, Emma J and Kleinhenz, Maureen T and Wilcock, Donna M},
  title = {Age-related cerebral amyloid angiopathy accumulation in the APPSw mouse model is associated with perivascular inflammation and brain-wide vascular and inflammatory gene and protein changes},
  journal = {Neurobiology of Disease},
  year = {2025},
  doi = {10.1016/j.nbd.2025.107013}
}
Kostenlos starten →